Center for Vaccine Development and Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, MD, USA.
PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, USA.
Vaccine. 2021 Apr 8;39(15):2165-2176. doi: 10.1016/j.vaccine.2021.02.037. Epub 2021 Feb 19.
SARS-CoV-2 vaccines will be deployed to countries with limited immunization systems.
We assessed the effect of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in a simulated WHO African Region country using region-specific data on immunization, population, healthcare workers (HCWs), cold storage capacity (quartile values for national and subnational levels), and characteristics of an approved SARS-CoV-2 vaccine. We calculated monthly increases in vaccine doses, doses per vaccinator, and cold storage volumes for four-month SARS-CoV-2 vaccination campaigns targeting risk groups compared to routine immunization baselines.
Administering SARS-CoV-2 vaccines to risk groups would increase total monthly doses by 27.0% for ≥ 65 years, 91.7% for chronic diseases patients, and 1.1% for HCWs. Assuming median nurse density estimates adjusted for absenteeism and proportion providing immunization services, SARS-CoV-2 vaccination campaigns would increase total monthly doses per vaccinator by 29.3% for ≥ 65 years, 99.6% for chronic diseases patients, and 1.2% for HCWs. When we applied quartiles of actual African Region country vaccine storage capacity, routine immunization vaccine volumes exceeded national-level storage capacity for at least 75% of countries, but subnational levels had sufficient storage capacity for SARS-CoV-2 vaccines for at least 75% of countries.
In the WHO African Region, SARS-CoV-2 vaccination campaigns would substantially increase doses per vaccinator and cold storage capacity requirements over routine immunization baselines. Pandemic vaccination campaigns would increase storage requirements of national-level stores already at their limits, but sufficient capacity exists at subnational levels. Immediate attention to strengthening immunization systems is essential to support pandemic responses.
SARS-CoV-2 疫苗将在免疫体系有限的国家/地区部署。
我们使用特定于区域的免疫、人口、卫生保健工作者(HCW)、冷藏能力(国家和国家以下各级的四分位数值)以及已批准的 SARS-CoV-2 疫苗的特征的数据,评估在模拟的世界卫生组织非洲区域国家中部署 SARS-Cov-2 疫苗对冷藏能力和免疫工作量的影响。我们计算了与常规免疫基线相比,针对风险群体的四个月 SARS-CoV-2 疫苗接种运动每月增加的疫苗剂量、每名接种者的剂量和冷藏量。
为≥65 岁的人群、慢性疾病患者和 HCW 接种 SARS-CoV-2 疫苗将使总每月剂量分别增加 27.0%、91.7%和 1.1%。假设调整缺勤率和提供免疫服务比例后的中位护士密度估计数,SARS-CoV-2 疫苗接种运动将使≥65 岁的人群、慢性疾病患者和 HCW 的每名接种者的总每月剂量分别增加 29.3%、99.6%和 1.2%。当我们应用非洲区域实际国家疫苗储存能力四分位数时,至少 75%的国家的常规免疫疫苗量超过了国家一级的储存能力,但至少 75%的国家的国家以下各级都有足够的 SARS-CoV-2 疫苗储存能力。
在世界卫生组织非洲区域,SARS-CoV-2 疫苗接种运动将使每名接种者的剂量和冷藏能力需求大大超过常规免疫基线。大流行疫苗接种运动将增加已经达到极限的国家一级储存库的储存需求,但国家以下各级有足够的能力。立即关注加强免疫系统对于支持大流行应对至关重要。